期刊
JOURNAL OF MOLECULAR MODELING
卷 23, 期 3, 页码 -出版社
SPRINGER
DOI: 10.1007/s00894-017-3258-3
关键词
XIAP; Caspase3; SMAC; RIPK2; Clinical variants; Proteinmodeling; Undiagnosed and rare diseases
类别
资金
- NHGRI NIH HHS [U01 HG007943] Funding Source: Medline
- NHLBI NIH HHS [R01 HL069321] Funding Source: Medline
- NIEHS NIH HHS [K01 ES025435] Funding Source: Medline
Protein modeling and molecular dynamics hold a unique toolset to aide in the characterization of clinical variants that may result in disease. Not only do these techniques offer the ability to study under characterized proteins, but they do this with the speed that is needed for time-sensitive clinical cases. In this paper we retrospectively study a clinical variant in the XIAP protein, C203Y, while addressing additional variants seen in patients with similar gastrointestinal phenotypes as the C203Y mutation. In agreement with the clinical tests performed on the C203Y patient, protein modeling and molecular dynamics suggest that direct interactions with RIPK2 and Caspase3 are altered by the C203Y mutation and subsequent loss of Zn coordination in the second BIR domain of XIAP. Interestingly, the variant does not appear to alter interactions with SMAC, resulting in further damage to the caspase and NOD2 pathways. To expand the computational strategy designed when studying XIAP, we have applied the molecular modeling tools to a list of 140 variants seen in CFTR associated with cystic fibrosis, and a list of undiagnosed variants in 17 different genes. This paper shows the exciting applications of molecular modeling in the classification and characterization of genetic variants identified in next generation sequencing.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据